Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.59NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.59NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.24.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.24.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.17.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.17.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.17.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.14.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HL.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HL.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HL.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.42.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.42.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.42.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DZ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DZ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DZ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.14.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used